PA
HLF icon

PharVision Advisers’s Herbalife HLF Stock Holding History

PharVision Advisers’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,930
Closed -$176K – 90
2026
Q1 		$176K Sell
11,930
-37,985
-76% -$621K 1.78% 4
2025
Q4 		$643K Sell
49,915
-7,405
-13% -$78.4K 0.33% 8
2025
Q3 		$484K Buy
+57,320
New +$541K 0.27% 27
2025
Q1 		– Sell
-107,691
Closed -$720K – 382
2024
Q4 		$720K Buy
+107,691
New +$800K 0.61% 14

Other funds holding HLF

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.49B AUM 10.92% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SP
Solel Partners Boston, Massachusetts $588M AUM 14.47% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PharVision Advisers's HLF Position: Q2 2026 in Review

PharVision Advisers sold out of Herbalife (HLF) in Q2 2026, closing a stake of 11,930 shares — an estimated $176K sold.

PharVision Advisers first reported a position in HLF in Q4 2024 and held it in 4 quarters. The position peaked at $720K in Q4 2024. 235 funds tracked by Wall St. Rank hold HLF as of Q2 2026.

  • PharVision Advisers reported no remaining Herbalife position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 11,930 Herbalife shares in Q2 2026, an estimated $176K.
  • PharVision Advisers first reported a position in Herbalife in Q4 2024 and held it in 4 quarters.
  • PharVision Advisers's Herbalife position peaked at $720K in Q4 2024.
  • 235 funds tracked by Wall St. Rank held Herbalife as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.